History
Established in 1993 through the acquisition of a Sanofi plant, the company's initial focus was on producing sterile single-dose polyethylene products like saline, asthma treatments, and eye drops. Making use of Blow Fill Seal (BFS) technology in 1995 allowed the creation of sterile doses in a single manufacturing step. By 1997, the company had expanded its presence to global markets, exporting to Europe and building expertise for international customers. Unither's growth continued with the acquisition of a second sterile single-dose unit manufacturing plant in Coutances, France, in 2002. In 2005, they furthered their expansion by acquiring Créapharm, specializing in effervescent tablets. The launch of Unistick® stick-packs in 2006 marked a significant advancement in providing single-dose stick solutions. Over the years, Unither continued to expand its technologies, facilities, and international reach, including the acquisition of the Colomiers site in 2009, the launch of Uniflash® in 2010, the opening of a plant in Butantã, São Paulo, Brazil in 2011, and the acquisition of various plants, including the Novartis plant in 2022